Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis
出版年份 2012 全文链接
标题
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 24, Issue 1, Pages 101-108
出版商
Oxford University Press (OUP)
发表日期
2012-09-22
DOI
10.1093/annonc/mds248
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- LAPATAX: A randomized phase II trial of FEC-docetaxel combined with lapatinib and/or trastuzumab as neoadjuvant therapy of HER2-positive breast cancer—EORTC 10054 trial.
- (2017) D. A. Cameron et al. JOURNAL OF CLINICAL ONCOLOGY
- Abstract 105: An epigenetic vicious cycle of DNMT, protein Tyrosine phosphatase receptor type R, and the MAPK pathway in cancer metastasis
- (2012) Po-Hsuan Su et al. CANCER RESEARCH
- Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
- (2012) Takayuki Iwamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Should liver metastases of breast cancer be biopsied to improve treatment choice?
- (2011) G. Curigliano et al. ANNALS OF ONCOLOGY
- Carminomycin I Is an Apoptosis Inducer That Targets the Golgi Complex in Clear Cell Renal Carcinoma Cells
- (2011) G. M. Woldemichael et al. CANCER RESEARCH
- Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis
- (2011) Paul St. Romain et al. HUMAN PATHOLOGY
- Breast cancer — one term, many entities?
- (2011) Nicholas R. Bertos et al. JOURNAL OF CLINICAL INVESTIGATION
- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
- (2011) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
- (2011) Naoki Niikura et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
- (2011) Eitan Amir et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss
- (2011) Giuseppe Bogina et al. VIRCHOWS ARCHIV
- HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
- (2010) Ulla Wilking et al. BREAST CANCER RESEARCH AND TREATMENT
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis
- (2010) L. Pusztai et al. ONCOLOGIST
- The Need to Examine Metastatic Tissue at the Time of Progression of Breast Cancer: Is Re-biopsy a Necessity or a Luxury?
- (2010) Mustafa Khasraw et al. Current Oncology Reports
- Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
- (2009) C. Liedtke et al. ANNALS OF ONCOLOGY
- Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
- (2009) C. Simmons et al. ANNALS OF ONCOLOGY
- Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
- (2009) E. A. Mittendorf et al. CLINICAL CANCER RESEARCH
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
- HER-2/neu expression in primary and metastatic breast cancer
- (2008) Elyse E. Lower et al. BREAST CANCER RESEARCH AND TREATMENT
- Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases
- (2008) J. M. Wu et al. CLINICAL CANCER RESEARCH
- Comparison of HER-2 and Hormone Receptor Expression in Primary Breast Cancers and Asynchronous Paired Metastases: Impact on Patient Management
- (2008) V. Guarneri et al. ONCOLOGIST
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started